There are about 43,000 jobs in the pharmaceutical industry in Switzerland
Keystone
The president of pharmaceutical giant Novartis has announced job cuts in an interview with Swiss newspaper NZZ am Sonntag.
This content was published on
1 minute
Keystone-SDA/ds
Jörg Reinhardt said the Basel-based company wants to streamline its production sites and administration worldwide.
“This will affect various plants globally and will also have an impact on Switzerland,” Reinhardt was quoted as saying in the Sunday edition of the newspaper.
The impact will be felt not only at company headquarters in Basel but also probably in the Aargau plant in Stein, where 2,000 employees still produce many medicines using traditional methods, according to the newspaper.
Reinhardt justified the cost reduction plans citing the drop in net prices in the United States over the past year.
He said prices would be “one to two percent” lower than in the previous year due to discounts granted to major buyers.
Since the pharmaceutical industry generates on average half of its profits in the US, this decline is significant.
“We are preparing for something to happen in the US price system in the medium term that will have an impact on the entire pharmaceutical industry,” Reinhardt said.
More
More
Eye on the Multinationals: Your questions become our stories
This content was published on
Do you work for or would like to work for a multinational company? Are you concerned about the impact of multinational companies at home and abroad?
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland’s love affair with multinationals
This content was published on
Switzerland is home to some of the largest global companies. But what value do they bring to the Swiss economy and society?
As trust declines globally, can Switzerland remain an exception?
This content was published on
Switzerland is one of the most trusted countries despite being home to some of the largest companies in the most distrusted sectors.
This content was published on
The government has finalised its proposal for overhauling the Swiss corporate tax landscape after voters rejected initial plans a year ago.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.